Inventors:
McClellan M. Walther - Gaithersburg MD
Renato V. LaRocca - Sterling VA
Charles E. Myers - Bethesda MD
Cy A. Stein - North Potomac MD
W. Marston Linehan - Rockville MD
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
International Classification:
A61K 3117
Abstract:
A method is disclosed for the treatment of hypercalcemia in a patient, by administering to the patient an effective amount of suramin, or an active analogue thereof, for lowering calcium plasma levels in the patient. Human data shows a single course of treatment lowers plasma calcium levels to normal for three months.